Europe Joint Pain Injections Market Size, Share & Industry Trends Analysis Report By Injection Type (Interleukin Inhibitors, Hyaluronic Acid Injections), By Distribution Channel, By Joint Type Channel, By Country and Growth Forecast, 2022

List of Tables

The Europe Joint Pain Injections Market would witness market growth of 7.2% CAGR during the forecast period (2022-2028).

Hyaluronic acid injections are used to restore the lost lubricant in the event of osteoarthritis, a kind of arthritis in which the hyaluronic acid that serves as natural lubrication in the joint degrades. Joint pain injections are typically administered directly into the joints to ensure optimal effectiveness.

A local anesthetic and medication are administered to the patients during the facet joint injection, a minimally invasive technique, to numb the facet joint and relieve discomfort. The healthcare sector is expected to experience significant growth in the coming years, mostly due to the development of "value-based" care models.

This development foreshadows the market's expansion for joint pain injections, which will double in size over the years. The primary driver of facet joint injections during the projection period is likely to be the rising desire for non-surgical therapies. Also, increasing emphasis on efficient pain management may significantly contribute to the overall development of the joint pain injections Market during the evaluation period. Pain specialists use facet joint injections to treat chronic spinal diseases effectively, and they continue to be one of the market players' primary sources of income.

Falls and fractures were the most prevalent and severe health problems that older individuals in England encountered. The human cost includes misery, agony, damage, loss of autonomy, loss of self-assurance, and even death. As a result, health services are both expensive and abundant. According to the Falls and Fracture Consensus Statement, published by Public Health England and the National Falls Prevention Coordination Group in January 2017, the total cost of fragility fractures in the United Kingdom is estimated to be £4.4 billion, of which £1.1 billion is allocated to social care. Fractures of the hip account for roughly two billion dollars of this total. This increases the incidence of joint pains among fracture sufferers, raising the need for joint pain injections in Europe.

The Germany market dominated the Europe Joint Pain Injections Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $648.5 Million by 2028. The UK market is exhibiting a CAGR of 6.4% during (2022 - 2028). Additionally, The France market would experience a CAGR of 8% during (2022 - 2028).

Based on Injection Type, the market is segmented into Interleukin Inhibitors, Hyaluronic Acid Injections, and Others. Based on Distribution Channel, the market is segmented into Drug Stores & Retail Pharmacies, Hospital Pharmacies, and Others. Based on Joint Type Channel, the market is segmented into Knee & Ankle, Shoulder & Elbow, Hip Joint, Facet Joints of the Spine, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bioventus Inc., Pacira BioSciences, Inc., AbbVie, Inc., Teva Pharmaceuticals Industries Ltd., Pfizer, Inc., Anika Therapeutics, Inc., Zimmer Biomet Holdings, Inc., Eli Lilly And Company, Ferring Holdings SA, and Sanofi S.A.

Scope of the Study

Market Segments covered in the Report:

By Injection Type

Interleukin Inhibitors
Hyaluronic Acid Injections
Others

By Distribution Channel

Drug Stores & Retail Pharmacies
Hospital Pharmacies
Others

By Joint Type

Knee & Ankle
Shoulder & Elbow
Hip Joint
Facet Joints of the Spine
Others

By Country

Germany
UK
France
Russia
Spain
Italy
Rest of Europe

Companies Profiled

Bioventus Inc.
Pacira BioSciences, Inc.
AbbVie, Inc.
Teva Pharmaceuticals Industries Ltd.
Pfizer, Inc.
Anika Therapeutics, Inc.
Zimmer Biomet Holdings, Inc.
Eli Lilly And Company
Ferring Holdings SA
Sanofi S.A.

Unique Offerings from KBV Research

Exhaustive coverage
Highest number of market tables and figures
Subscription based model available
Guaranteed best price
Assured post sales research support with 10% customization free

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 Europe Joint Pain Injections Market, by Injection Type
- 1.4.2 Europe Joint Pain Injections Market, by Distribution Channel
- 1.4.3 Europe Joint Pain Injections Market, by Joint Type
- 1.4.4 Europe Joint Pain Injections Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview

2.1 Introduction
- 2.1.1 Overview
  - 2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints

Chapter 3. Europe Joint Pain Injections Market by Injection Type

3.1 Europe Interleukin Inhibitors Market by Country
3.2 Europe Hyaluronic Acid Injections Market by Country
3.3 Europe Others Market by Country

Chapter 4. Europe Joint Pain Injections Market by Distribution Channel

4.1 Europe Drug Stores & Retail Pharmacies Market by Country
4.2 Europe Hospital Pharmacies Market by Country
4.3 Europe Others Market by Country

Chapter 5. Europe Joint Pain Injections Market by Joint Type

5.1 Europe Knee & Ankle Market by Country
5.2 Europe Shoulder & Elbow Market by Country
5.3 Europe Hip Joint Market by Country
5.4 Europe Facet Joints of the Spine Market by Country
5.5 Europe Others Market by Country

Chapter 6. Europe Joint Pain Injections Market by Country

6.1 Germany Joint Pain Injections Market
- 6.1.1 Germany Joint Pain Injections Market by Injection Type
- 6.1.2 Germany Joint Pain Injections Market by Distribution Channel
- 6.1.3 Germany Joint Pain Injections Market by Joint Type
6.2 UK Joint Pain Injections Market
- 6.2.1 UK Joint Pain Injections Market by Injection Type
- 6.2.2 UK Joint Pain Injections Market by Distribution Channel
- 6.2.3 UK Joint Pain Injections Market by Joint Type
6.3 France Joint Pain Injections Market
- 6.3.1 France Joint Pain Injections Market by Injection Type
- 6.3.2 France Joint Pain Injections Market by Distribution Channel
- 6.3.3 France Joint Pain Injections Market by Joint Type
6.4 Russia Joint Pain Injections Market
- 6.4.1 Russia Joint Pain Injections Market by Injection Type
- 6.4.2 Russia Joint Pain Injections Market by Distribution Channel
- 6.4.3 Russia Joint Pain Injections Market by Joint Type
6.5 Spain Joint Pain Injections Market
- 6.5.1 Spain Joint Pain Injections Market by Injection Type
- 6.5.2 Spain Joint Pain Injections Market by Distribution Channel
- 6.5.3 Spain Joint Pain Injections Market by Joint Type
6.6 Italy Joint Pain Injections Market
- 6.6.1 Italy Joint Pain Injections Market by Injection Type
- 6.6.2 Italy Joint Pain Injections Market by Distribution Channel
- 6.6.3 Italy Joint Pain Injections Market by Joint Type
6.7 Rest of Europe Joint Pain Injections Market
- 6.7.1 Rest of Europe Joint Pain Injections Market by Injection Type
- 6.7.2 Rest of Europe Joint Pain Injections Market by Distribution Channel
- 6.7.3 Rest of Europe Joint Pain Injections Market by Joint Type

Chapter 7. Company Profiles

7.1 Bioventus Inc.
- 7.1.1 Company Overview
- 7.1.2 Financial Analysis
- 7.1.3 Regional Analysis
- 7.1.4 Research & Development Expenses
- 7.1.5 Recent strategies and developments:
  - 7.1.5.1 Product Launches and Product Expansions:
7.2 Pacira BioSciences, Inc.
- 7.2.1 Company Overview
- 7.2.2 Financial Analysis
- 7.2.3 Research & Development Expenses
- 7.2.4 Recent strategies and developments:
  - 7.2.4.1 Acquisition and Mergers:
7.3 AbbVie, Inc.
- 7.3.1 Company Overview
- 7.3.2 Financial Analysis
- 7.3.3 Regional Analysis
- 7.3.4 Research & Development Expense
- 7.3.5 Recent strategies and developments:
  - 7.3.5.1 Trails and Approvals:
7.4 Teva Pharmaceutical Industries Ltd.
- 7.4.1 Company Overview
- 7.4.2 Financial Analysis
- 7.4.3 Regional Analysis
- 7.4.4 Research & Development Expenses
7.5 Pfizer, Inc.
- 7.5.1 Company Overview
- 7.5.2 Financial Analysis
- 7.5.3 Regional & Segmental Analysis
- 7.5.4 Research & Development Expense
7.6 Anika Therapeutics, Inc.
- 7.6.1 Company Overview
- 7.6.2 Financial Analysis
- 7.6.3 Regional Analysis
- 7.6.4 Research & Development Expenses
7.7 Zimmer Biomet Holdings, Inc.
- 7.7.1 Company Overview
- 7.7.2 Financial Analysis
- 7.7.3 Regional Analysis
- 7.7.4 Research & Development Expense
7.8 Eli Lilly And Company
- 7.8.1 Company Overview
- 7.8.2 Financial Analysis
- 7.8.3 Regional Analysis
- 7.8.4 Research & Development Expenses
7.9 Ferring Holdings SA
- 7.9.1 Company Overview
- 7.9.2 Financial Analysis
- 7.9.3 Regional Analysis
- 7.9.4 Research and Development Expense
7.10. Sanofi S.A.
- 7.10.1 Company Overview
- 7.10.2 Financial Analysis
- 7.10.3 Segmental and Regional Analysis
- 7.10.4 Research & Development Expense

LIST OF TABLES

TABLE 1 Europe Joint Pain Injections Market, 2018 - 2021, USD Million
TABLE 2 Europe Joint Pain Injections Market, 2022 - 2028, USD Million
TABLE 3 Europe Joint Pain Injections Market by Injection Type, 2018 - 2021, USD Million
TABLE 4 Europe Joint Pain Injections Market by Injection Type, 2022 - 2028, USD Million
TABLE 5 Europe Interleukin Inhibitors Market by Country, 2018 - 2021, USD Million
TABLE 6 Europe Interleukin Inhibitors Market by Country, 2022 - 2028, USD Million
TABLE 7 Europe Hyaluronic Acid Injections Market by Country, 2018 - 2021, USD Million
TABLE 8 Europe Hyaluronic Acid Injections Market by Country, 2022 - 2028, USD Million
TABLE 9 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 10 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 11 Europe Joint Pain Injections Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 12 Europe Joint Pain Injections Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 13 Europe Drug Stores & Retail Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 14 Europe Drug Stores & Retail Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 15 Europe Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 16 Europe Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 17 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 18 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 19 Europe Joint Pain Injections Market by Joint Type, 2018 - 2021, USD Million
TABLE 20 Europe Joint Pain Injections Market by Joint Type, 2022 - 2028, USD Million
TABLE 21 Europe Knee & Ankle Market by Country, 2018 - 2021, USD Million
TABLE 22 Europe Knee & Ankle Market by Country, 2022 - 2028, USD Million
TABLE 23 Europe Shoulder & Elbow Market by Country, 2018 - 2021, USD Million
TABLE 24 Europe Shoulder & Elbow Market by Country, 2022 - 2028, USD Million
TABLE 25 Europe Hip Joint Market by Country, 2018 - 2021, USD Million
TABLE 26 Europe Hip Joint Market by Country, 2022 - 2028, USD Million
TABLE 27 Europe Facet Joints of the Spine Market by Country, 2018 - 2021, USD Million
TABLE 28 Europe Facet Joints of the Spine Market by Country, 2022 - 2028, USD Million
TABLE 29 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 30 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 31 Europe Joint Pain Injections Market by Country, 2018 - 2021, USD Million
TABLE 32 Europe Joint Pain Injections Market by Country, 2022 - 2028, USD Million
TABLE 33 Germany Joint Pain Injections Market, 2018 - 2021, USD Million
TABLE 34 Germany Joint Pain Injections Market, 2022 - 2028, USD Million
TABLE 35 Germany Joint Pain Injections Market by Injection Type, 2018 - 2021, USD Million
TABLE 36 Germany Joint Pain Injections Market by Injection Type, 2022 - 2028, USD Million
TABLE 37 Germany Joint Pain Injections Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 38 Germany Joint Pain Injections Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 39 Germany Joint Pain Injections Market by Joint Type, 2018 - 2021, USD Million
TABLE 40 Germany Joint Pain Injections Market by Joint Type, 2022 - 2028, USD Million
TABLE 41 UK Joint Pain Injections Market, 2018 - 2021, USD Million
TABLE 42 UK Joint Pain Injections Market, 2022 - 2028, USD Million
TABLE 43 UK Joint Pain Injections Market by Injection Type, 2018 - 2021, USD Million
TABLE 44 UK Joint Pain Injections Market by Injection Type, 2022 - 2028, USD Million
TABLE 45 UK Joint Pain Injections Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 46 UK Joint Pain Injections Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 47 UK Joint Pain Injections Market by Joint Type, 2018 - 2021, USD Million
TABLE 48 UK Joint Pain Injections Market by Joint Type, 2022 - 2028, USD Million
TABLE 49 France Joint Pain Injections Market, 2018 - 2021, USD Million
TABLE 50 France Joint Pain Injections Market, 2022 - 2028, USD Million
TABLE 51 France Joint Pain Injections Market by Injection Type, 2018 - 2021, USD Million
TABLE 52 France Joint Pain Injections Market by Injection Type, 2022 - 2028, USD Million
TABLE 53 France Joint Pain Injections Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 54 France Joint Pain Injections Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 55 France Joint Pain Injections Market by Joint Type, 2018 - 2021, USD Million
TABLE 56 France Joint Pain Injections Market by Joint Type, 2022 - 2028, USD Million
TABLE 57 Russia Joint Pain Injections Market, 2018 - 2021, USD Million
TABLE 58 Russia Joint Pain Injections Market, 2022 - 2028, USD Million
TABLE 59 Russia Joint Pain Injections Market by Injection Type, 2018 - 2021, USD Million
TABLE 60 Russia Joint Pain Injections Market by Injection Type, 2022 - 2028, USD Million
TABLE 61 Russia Joint Pain Injections Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 62 Russia Joint Pain Injections Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 63 Russia Joint Pain Injections Market by Joint Type, 2018 - 2021, USD Million
TABLE 64 Russia Joint Pain Injections Market by Joint Type, 2022 - 2028, USD Million
TABLE 65 Spain Joint Pain Injections Market, 2018 - 2021, USD Million
TABLE 66 Spain Joint Pain Injections Market, 2022 - 2028, USD Million
TABLE 67 Spain Joint Pain Injections Market by Injection Type, 2018 - 2021, USD Million
TABLE 68 Spain Joint Pain Injections Market by Injection Type, 2022 - 2028, USD Million
TABLE 69 Spain Joint Pain Injections Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 70 Spain Joint Pain Injections Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 71 Spain Joint Pain Injections Market by Joint Type, 2018 - 2021, USD Million
TABLE 72 Spain Joint Pain Injections Market by Joint Type, 2022 - 2028, USD Million
TABLE 73 Italy Joint Pain Injections Market, 2018 - 2021, USD Million
TABLE 74 Italy Joint Pain Injections Market, 2022 - 2028, USD Million
TABLE 75 Italy Joint Pain Injections Market by Injection Type, 2018 - 2021, USD Million
TABLE 76 Italy Joint Pain Injections Market by Injection Type, 2022 - 2028, USD Million
TABLE 77 Italy Joint Pain Injections Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 78 Italy Joint Pain Injections Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 79 Italy Joint Pain Injections Market by Joint Type, 2018 - 2021, USD Million
TABLE 80 Italy Joint Pain Injections Market by Joint Type, 2022 - 2028, USD Million
TABLE 81 Rest of Europe Joint Pain Injections Market, 2018 - 2021, USD Million
TABLE 82 Rest of Europe Joint Pain Injections Market, 2022 - 2028, USD Million
TABLE 83 Rest of Europe Joint Pain Injections Market by Injection Type, 2018 - 2021, USD Million
TABLE 84 Rest of Europe Joint Pain Injections Market by Injection Type, 2022 - 2028, USD Million
TABLE 85 Rest of Europe Joint Pain Injections Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 86 Rest of Europe Joint Pain Injections Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 87 Rest of Europe Joint Pain Injections Market by Joint Type, 2018 - 2021, USD Million
TABLE 88 Rest of Europe Joint Pain Injections Market by Joint Type, 2022 - 2028, USD Million
TABLE 89 Key Information - Bioventus Inc.
TABLE 90 Key Information - Pacira BioSciences, Inc.
TABLE 91 Key information - AbbVie, Inc.
TABLE 92 Key Information - Teva Pharmaceuticals Industries Ltd.
TABLE 93 Key Information - Pfizer, Inc.
TABLE 94 Key Information - Anika Therapeutics, Inc.
TABLE 95 key Information - Zimmer Biomet Holdings, Inc.
TABLE 96 Key Information - Eli Lilly And Company
TABLE 97 key information - Ferring Holdings SA
TABLE 98 Key Information - Sanofi S.A.

List of Figures

FIG 1 Methodology for the research

Europe Joint Pain Injections Market Size, Share & Industry Trends Analysis Report By Injection Type (Interleukin Inhibitors, Hyaluronic Acid Injections), By Distribution Channel, By Joint Type Channel, By Country and Growth Forecast, 2022 - 2028

Description

Table of Contents